IGF2 and urinary bladder carcinoma: Similarly, IGF2 LOI has been reported in a variety of human cancers at widely varying rates, including Wilms' tumor, colorectal cancer, hepatoma, lung cancer, ovarian cancer, bladder cancer, leiomyosarcoma, and esophagus cancer [39].